Favorable Media Coverage Somewhat Unlikely to Affect Clorox Company (The) (CLX) Stock Price

News articles about Clorox Company (The) (NYSE:CLX) have trended positive on Wednesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Clorox Company (The) earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.4761116983082 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

A number of equities analysts have recently weighed in on the stock. Consumer Edge raised shares of Clorox Company (The) from a “neutral” rating to an “outperform” rating in a research note on Friday, November 10th. Zacks Investment Research raised shares of Clorox Company (The) from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Morgan Stanley reduced their target price on shares of Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Jefferies Group LLC reiterated a “hold” rating and set a $132.00 price objective on shares of Clorox Company (The) in a report on Wednesday, November 1st. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a report on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $128.72.

Shares of Clorox Company (CLX) opened at $135.31 on Wednesday. The stock has a market cap of $17,417.03, a P/E ratio of 24.34, a P/E/G ratio of 3.68 and a beta of 0.39. Clorox Company has a 1 year low of $112.28 and a 1 year high of $141.76. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the company earned $1.36 earnings per share. Clorox Company (The)’s revenue for the quarter was up 4.0% on a year-over-year basis. analysts expect that Clorox Company will post 5.58 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.48%. Clorox Company (The)’s dividend payout ratio (DPR) is 61.88%.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. Insiders sold 41,293 shares of company stock valued at $5,560,303 in the last ninety days. 1.00% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://weekherald.com/2017/11/15/favorable-media-coverage-somewhat-unlikely-to-affect-clorox-company-the-clx-stock-price.html.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply